Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Alkermes Announces Initiation of Phase 3 Study of ALKS 3831 in Young Adult Patients | 2 | 680 | June 8, 2017 | |
| ALKS3831 - On trial | 5 | 969 | April 18, 2016 | |
| Positive phase II Clinical Trial Results of ALKS 3831 in Schizophrenia | 0 | 519 | January 7, 2015 | |
| Alkermes (ALKS) Announces FDA Acceptance of ALKS 3831 NDA for Treatment of Schizophrenia and Bipolar I Disorder | 0 | 295 | January 28, 2020 | |
| Alkermes Completes Patient Enrollment in Phase 2 Study of ALKS 3831, a New Oral Antipsychotic | 8 | 927 | September 4, 2014 |